γ-MSH, sodium metabolism, and salt-sensitive hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Humphreys, Michael H ^a,b,c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Central nervous system; Melanotropin; Neurointermediate lobe; Peptide hormone; Pituitary; Proopiomelanocortin

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN DERIVATIVE; BETA INTERMEDIN; CORTICOTROPIN; GAMMA INTERMEDIN; HORMONE PRECURSOR; HORMONE RECEPTOR; INTERMEDIN; INTERMEDIN RECEPTOR; MELANOCORTIN RECEPTOR; PROOPIOMELANOCORTIN; SODIUM; SODIUM CHLORIDE;

ADRENERGIC STIMULATION; ANIMAL; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CHEMISTRY; EVIDENCE BASED MEDICINE; GENETIC CONSERVATION; HEMODYNAMICS; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; IATROGENIC DISEASE; KIDNEY FUNCTION; METABOLISM; NATRIURESIS; NEPHRECTOMY; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SODIUM EXCRETION; SODIUM INTAKE; SODIUM METABOLISM; STRUCTURE ACTIVITY RELATION;

EID: 1342268010     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00365.2003     Document Type: Review

References (134)

1. Adan RA and Gispen WH. Brain melanocortin receptors: from cloning to function. Peptides 18: 1279-1287, 1997.
2. Ali-Rachedi A, Ferri GL, Varndell IM, Van Noorden S, Schot LPC, Ling N, Bloom SR, and Polak JM. Immunocytochemical evidence for the presence of γ-MSH-like immunoreactivity in pituitary corticotrophs and ACTH-producing tumors. Neuroendocrinology 37: 427-433, 1983.
3. Allen RG, Peng B, Pellegrino MJ, Miller ED, Grandy DK, Lundblad JR, Washburn CL, and Pintar JE. Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2. J Neurosci 21: 5864-5870, 2001.
4. Autelitano DJ, Lundblad JR, Blum M, and Roberts JL. Hormonal regulation of POMC gene expression. Annu Rev Physiol 51: 715-726, 1989.
5. Ayus JC and Humphreys MH. Hemodynamic and renal functional changes after unilateral nephrectomy in the dog: role of carotid sinus baroreceptors. Am J Physiol Renal Fluid Electrolyte Physiol 242: F181-F189, 1982.
6. Benjannet S, Savaria D, Chretien M, and Seidah NB. 7B2 is a specific intracellular binding protein of the prohormone convertase PC2. J Neurochem 64: 2303-2311, 1995.
7. Berman Y, Mzhavia N, Polonskaia A, Furuta M, Steiner DF, Pintar JE, and Devi LA. Defective prodynorphin processing in mice lacking prohormone convertase PC2. J Neurochem 75: 1763-1770, 2000.
8. Braas KM, Hendley ED, and May V. Anterior pituitary proopiomelanocortin expression is decreased in hypertensive rat strains. Endocrinology 134: 196-205, 1994.
9. Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, and Horber FF. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 348: 1096-1103, 2003.
10. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher J, and Cone RD. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141: 3518-3521, 2000.
11. Callahan MF, Cunningham JT, Kirby RF, Johnson AK, and Gruber KA. Role of the anteroventral third ventricle (AV3V) region of the rat brain in the pressor response to gamma 2-melanocyte stimulating hormone (gamma 2-MSH). Brain Res 444: 177-180, 1988.
12. Chandramohan G, Ni XP, Kalinyak JE, and Humphreys MH. Dietary sodium modulates mRNA abundance of enzymes involved in pituitary processing of proopiomelanocortin. Pituitary 4: 231-237, 2001.
13. Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, and Cone RD. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91: 789-798, 1997.
14. Chen XW, Ying WZ, Valentin JP, Ling KT, Lin SY, Wiedemann E, and Humphreys MH. Mechanism of the natriuretic action of γ -melanocyte-stimulating hormone. Am J Physiol Regul Integr Comp Physiol 272: R1946-R1953, 1997.
15. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38: 73-80, 1996.
16. Chiao H, Foster S, Thomas R, Lipton J, and Star RA. α-Melanocyte stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 97: 2038-2044, 1996.
17. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, and Star RA. α-Melanocyte stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99: 1165-1172, 1997.
18. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, and Star RA. α-Melanocyte stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 54: 765-774, 1998.
19. Clark AJL and Weber A. Molecular insights into inherited ACTH resistance syndromes. Trends Endocrinol Metab 5: 209-214, 1994.
20. Day R, Schafer MK, Watson SJ, Chretien M, and Seidah N. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol 6: 485-497, 1992.
21. DeBold CR, Nicholson WE, and Orth DN. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. Endocrinology 122: 2648-2657, 1988.
22. Desarnaud F, Labbe O, Eggerickx D, Vassart G, and Parmentier M. Molecular cloning, functional expression, and pharmacological characterization of a mouse melanocortin receptor gene. Biochem J 299: 367-373, 1994.
23. 2-melanocyte stimulating hormone and related melanotropins depend on the arousal potential of the rat. Eur J Pharmacol 233: 157-164, 1993.
24. 2-MSH) microinjected into the nucleus tractus solitarii of the rat. Naunyn Schmiedebergs Arch Pharmacol 349: 50-56, 1994.
25. DiBona GF and Kopp UC. Neural control of renal function. Annu Rev Physiol 77: 75-197, 1997.
26. Diezi J, Michoud-Hausel P, and Nicolas-Buxcel N. Studies on possible mechanisms of early functional compensatory adaptation in the remaining kidney. Yale J Biol Med 51: 265-270, 1978.
27. Dirks JH and Wong NLM. Acute functional adaptation to nephron loss. Micropuncture studies. Yale J Biol Med 51: 225-263, 1978.
28. Duchen LW. The effects of ingestion of hypertonic saline on the pituitary gland in the rat. A morphological study of the pars intermedia and posterior lobe. J Endocrinol 25: 162-168, 1962.
29. Dunbar JC and Lu H. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides 21: 211-217, 2000.
30. Edvinsson I, Ekman R, Hedner P, Sjoholm A, and Valdemarsson S. Gamma 2-MSH in congestive heart failure: relation to atrial natriuretic peptide, arginine vasopressin and catecholamines. J Intern Med 227: 183-187, 1990.
31. 2-MSH immunoreactivity in the human heart. Life Sci 45: 787-792, 1989.
32. Elkabes S and Loh YP. Effect of salt loading on proopiomelanocortin (POMC) messenger ribonucleic acid levels, POMC biosynthesis, and secretion of POMC products in the mouse pituitary gland. Endocrinology 123: 1754-1760, 1988.
33. Englaro W, Rezzonico R, Durand-Clement M, Lallemand D, Ortonne JP, and Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP induced melanogenesis in B-16 melanoma cells. J Biol Chem 270: 24315-24320, 1995.
34. Farooqi IS, Keogh JM, Yeo GSM, Lank EJ, Cheetham T, and O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348: 1085-1095, 2003.
35. Felder RA and Garland DS. POMC biosynthesis in the intermediate lobe of the spontaneously hypertensive rat. Am J Hypertens 2: 618-624, 1989.
36. Franco-Saenz R, Mulrow PJ, and Kim K. Idiopathic aldosteronism: a possible disease of the intermediate lobe of the pituitary. JAMA 251: 2555-2558, 1984.
37. Frankel MB, Aldred PG, and McDougall JG. Sodium status affects GC-B natriuretic receptor mRNA levels, but not GC-A or C receptor mRNA levels in the sheep kidney. Clin Sci (Colch) 86: 517-522, 1994.
38. Furuta M, Yano H, Shou A, Rouille A, Holst JJ, Carroll R, Ravazzola M, Orci L, Furuta H, and Steiner DF. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94: 6646-6651, 1997.
39. Furuta M, Zhou A, Webb G, Carroll R, Ravazzola M, Orci L, and Steiner DF. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem 276: 27197-27202, 2001.
40. Gaida W, Lang RE, Kraft K, Unger T, and Ganten D. Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence? Clin Sci (Colch) 68: 35-43, 1985.
41. Gantz I and Fong TM. The melanocortin system. Am J Physiol Endocrinol Metab 284: E468-E474, 2003.
42. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, and Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268: 8246-8250, 1993.
43. Griffing GT, Berelowits B, Hudson M, Salzman R, Manson JE, Aurrechia S, Melby JC, Pedersen RC, and Brownie AC. Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension. J Clin Invest 76: 163-169, 1985.
44. Gruber KA and Callahan MF. ACTH-(4-10) through γ-MSH: evidence for a new class of central autonomic nervous system-regulating peptides. Am J Physiol Regul Integr Comp Physiol 257: R681-R694, 1989.
45. Gruber KA and Eskridge SL. Central vasopressin system mediation of acute pressor effect of γ-MSH. Am J Physiol Endocrinol Metab 251: E134-E137, 1986.
46. Hao J and Rabkin SW. Differences in pituitary expression of proopiomelanocortin in Dahl salt-resistant and salt-sensitive rats on a high salt diet. Can J Physiol Pharmacol 74: 657-662, 1996.
47. Hill C and Dunbar JC. The effects of acute and chronic alpha melanocyte stimulating hormone (αMSH) on cardiovascular dynamics in conscious rats. Peptides 23: 1625-1630, 2002.
48. Howe A and Thody AJ. The effect of ingestion of hypertonic saline on the melanocyte-stimulating hormone content and histology of the pars intermedia of the rat pituitary gland. J Endocrinol 46: 201-208, 1970.
49. Hradec J and Horky K. Natriuretic and kaliuretic effect of melanocyte stimulating hormones in hamster. Endocr J 13: 145-152, 1979.
50. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 38: 3454-3461, 1995.
51. +-induced synmpathoexcitation and hypertension. Hypertension 39: 557-561, 2002.
52. Humphreys MH, Al-Bander H, Eneas JF, and Schambelan M. Factors determining electrolyte excretion and renin secretion after closure of an arteriovenous fistula in the dog. J Lab Clin Med 98: 89-98, 1981.
53. Humphreys MH and Ayus JC. Role of hemodynamic changes in the increased cation excretion after acute unilateral nephrectomy in the anesthetized dog. J Clin Invest 61: 590-596, 1978.
54. Humphreys MH, Ayus JC, and Stanton CJ. Prevention by vagotomy or atropine administration of the hemodynamic changes occurring after acute unilateral nephrectomy in the dog. Circ Res 46: 575-580, 1980.
55. Humphreys MH and Lin SY. Peptide hormones and the regulation of sodium excretion. Hypertension 11: 397-410, 1988.
56. Humphreys MH, Lin SY, and Wiedemann E. Renal nerves and the natriuresis following unilateral renal exclusion in the rat. Kidney Int 39: 63-70, 1991.
57. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, and Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.
58. Kivipelto L, Majane EA, Yang HYT, and Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J Comp Neurol 286: 269-287, 1989.
59. Kojima I, Kojima K, and Rasmussen H. Role of calcium and cAMP in the action of adrenocorticotropin in the action of adrenocorticotropin on aldosterone secretion. J Biol Chem 260: 4248-4256, 1985.
60. Konda Y, Gantz I, DelValle J, Shimoto Y, Miwa H, and Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269: 13162-13166, 1994.
61. Krude H, Biebermann H, Luck W, Horn R, Brabant G, and Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19: 155-157, 1998.
62. Krude H and Bruters A. Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol Metab 11: 15-22, 2000.
63. Laurent V, Kimble A, Peng B, Zhu P, Pintar JE, Steiner DF, and Lindberg I. Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci USA 99: 3087-3092, 2002.
64. Lee JY, Tobian L, Hanlon S, Hammer R, Johnson MA, and Iwai J. How is the signal transmitted in NaCl-induced hypertension? Hypertension 13: 668-675, 1989.
65. Lee YS, Poh LK, and Loke KY. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 87: 1423-1426, 2002.
66. Li SJ, Varga K, Archer P, Hruby VJ, Sharma SD, Kesterson RA, Cone RD, and Kunos G. Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte stimulating hormones. J Neurosci 16: 5182-5188, 1996.
67. Li WD, Joo EJ, Furlong EB, Galvin M, Abel K, Bell CJ, and Price RA. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int J Obes Relat Metab Disord 24: 206-210, 2000.
68. Lin SY, Chaves C, Wiedemann E, and Humphreys MH. A γ-MSH like peptide causes reflex natriuresis after acute unilateral nephrectomy. Hypertension 10: 619-627, 1987.
69. Lin SY and Humphreys MH. Centrally administered naloxone blocks reflex natriuresis after acute unilateral nephrectomy. Am J Physiol Renal Fluid Electrolyte Physiol 249: F390-F395, 1985.
70. Lin SY, Wiedemann E, Deschepper CF, Alper RN, and Humphreys MH. Prevention of reflex natriuresis after acute unilateral nephrectomy by neonatal administration of monosodium glutamate. Am J Physiol Renal Fluid Electrolyte Physiol 252: F276-F282, 1987.
71. Lin SY, Wiedemann E, and Humphreys MH. Role of the pituitary in the reflex natriuresis after acute unilateral nephrectomy. Am J Physiol Renal Fluid Electrolyte Physiol 249: F390-F395, 1985.
72. Lingueglia E, Champigny G, Lazdunski M, and Barbry P. Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 378: 730-733, 1995.
73. Lu H, Buison A, Jen KLC, and Dunbar JC. Leptin resistance in obesity is characterized by decreased sensitivity to proopiomelanocortin products. Peptides 21: 1479-1485, 2000.
74. Lymangrover JR, Buckalew VM, Harris J, Klein MC, and Gruber KA. Gamma-2 MSH is natriuretic in the rat. Endocrinology 116: 1227-1229, 1984.
75. Matsumura K, Tsuchihashi T, Abe I, and Iida M. Central α-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res 948: 143-148, 2002.
76. Matsumura K, Tsuchihashi T, Fujii K, and Iida M. Neural regulation of blood pressure by leptin and the related peptides. Regul Pept 114: 79-86, 2003.
77. Mayan H, Ling KT, Kalinyak JE, Sharma A, Wiedemann E, and Humphreys MH. Modulation by dietary salt intake of pituitary proopiomelanocortin (POMC) messenger RNA (mRNA) abundance in normotensive and hypertensive rats (Abstract). Hypertension 22: 417, 1993.
78. Mayan H, Ling KT, Lee EY, Wiedemann E, Kalinyak JE, and Humphreys MH. Dietary sodium intake modulates pituitary proopiomelanocortin messenger RNA abundance. Hypertension 28: 244-249, 1996.
79. Mayan H, Ni XP, Almog S, and Humphreys MH. Suppression of γ-melanocyte stimulating hormone secretion is accompanied by salt-sensitive hypertension in the rat. Hypertension 42: 962-967, 2003.
80. Mountjoy KG, Kong PL, Taylor JA, Willard DA, and Wilkison WO. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol Genomics 5: 11-19, 2001.
81. Mountjoy KG, Robbins LS, Mortrud MT, and Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 257: 1248-1251, 1992.
82. 2. Life Sci 31: 2555-2561, 1982.
83. Nakamura K and Cowley AW Jr. Sequential changes of cerebrospinal fluid sodium during the development of hypertension in Dahl rats. Hypertension 13: 243-249, 1989.
84. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang ACY, Cohen SN, and Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-β lipotropin precursor. Nature 278: 423-427, 1979.
85. Nemeroff CB, Grant LD, Bissette G, Ervin GN, Havell LE, and Prange AJ Jr. Growth, endocrinological, and behavioral deficits after monosodium L-glumatate in the rat: possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology 2: 179-196, 1977.
86. Ni XP, Bhargava A, Pearce D, and Humphreys MH. Dietary sodium intake modulates renal expression of melanocortin 3 receptor (MC3-R) mRNA and protein abundance in the rat (Abstract). J Am Soc Nephrol 13: 81A, 2002.
87. Ni XP, Butler AA, Cone RD, and Humphreys MH. Cardiovascular actions of γ-melanocyte stimulating hormone (γ-MSH): role of the melanocortin 3 receptor (MC3-R) (Abstract). J Am Soc Nephrol 14: 141A, 2003.
88. Ni XP, Kesterson RA, Sharma SD, Hruby VJ, Cone RD, Wiedemann E, and Humphreys MH. Prevention of reflex natriuresis after acute unilateral nephrectomy by melanocortin receptor antagonists. Am J Physiol Regul Integr Comp Physiol 274: R931-R938, 1998.
89. Ni XP, Pearce D, Butler AA, Cone RD, and Humphreys MH. Genetic disruption of γ-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 111: 1251-1258, 2003.
90. 2-MSH) for inducing cardiovascular effects in conscious rats. Br J Pharmacol 131: 1468-1474, 2000.
91. Nishimura M, Ohtsuka K, Takahashi H, and Yoshimura M. Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension. Hypertension 35: 443-450, 2000.
92. Oosterom J, Nijenhuis WA, Schaaper WM, Slootstra J, Meloen RH, Gispen WH, Burbach JP, and Adan RA. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors. J Biol Chem 274: 16853-16860, 1999.
93. Orias R and McCann SM. Natriuresis induced by alpha and beta melanocyte stimulating hormone (MSH) in rats. Endocrinology 90: 700-706, 1972.
94. Osamura RY, Watanabe K, Tanaka I, Nakai Y, and Imura H. Comparative immunohistochemical studies of γ-melanocyte stimulating hormone (γ-MSH) and adrenocorticotrophic hormone (ACTH) in the bovine and human pituitaries. Acta Endocrinol 96: 458-463, 1981.
95. Oyarce AM, Hand TA, Mains RE, and Eipper BE. Dopaminergic regulation of secretory granule-associated proteins in rat intermediate pituitary. J Neurochem 67: 229-241, 1996.
96. Pavia JM, Schioth HB, and Morris MJ. Role of MC4 receptors in the depressor and bradycardic effects of α-MSH in the nucleus tractus solitarii of the rat. Neuroreport 14: 703-707, 2003.
97. 3-Melanotropin binds with high affinity to the rat adrenal cortex. Endocrinology 112: 1279-1287, 1983.
98. Peters G. Compensatory adaptation of renal functions in the anesthetized rat. Am J Physiol 205: 1042-1048, 1963.
99. Price DA and Greenberg MJ. Structure of a molluscan cardioexcitatory neuropeptide. Science 197: 670-671, 1977.
100. Pritchard LE, Turnbull AV, and White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172: 411-421, 2002.
101. Qiu C, Valentin JP, Chen XW, Wiedemann E, and Humphreys MH. Acute unilateral nephrectomy elicits a specific increase in plasma of peptides derived from the N-terminal region of proopiomelanocortin. J Am Soc Nephrol 3: 1105-1112, 1992.
102. Ramaekers D, Beckers F, Demeulemeester H, Bert C, Denef C, and Aubert AE. Effects of melanocortins on cardiovascular regulation in rats. Clin Exp Pharmacol Physiol 29: 549-558, 2002.
103. Rapp JP and Dahl LK. Anatomical and protein electrophoretic observations on pituitary cleft colloid in rats genetically susceptible or resistant to salt hypertension. Lab Invest 30: 417-426, 1974.
104. Ribstein J and Humphreys MH. Renal nerves and cation excretion after acute reduction in functioning renal mass in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 246: F260-F266, 1984.
105. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, and Cone RD. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90: 8856-8860, 1993.
106. Roumy M and Zajac JM. Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345: 1-11, 1998.
107. Schalin-Jantti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, Krusius T, Mustajoki P, Heikinheimo M, and Kontula K. Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes 27: 70-74, 2003.
108. Schioth HB. The physiological role of melanocortin receptors. Vitam Horm 63: 195-232, 2001.
109. Schioth HB, Chhajlani V, Muceniece R, Lkusa V, and Wikberg JE. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sci 59: 797-801, 1996.
110. Schioth HB, Muceniece R, Wikberg JES, and Chhajlani V. Characterization of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol 288: 311-317, 1995.
111. Schioth HB, Phillips S, Rudzish R, Birch-Machin M, Jackson I, Wikberg JES, and Rees JL. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260: 488-491, 1999.
112. Smith AI and Funder JW. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9: 159-179, 1988.
113. Strazzullo P, Barbato A, Vuotto P, and Galletti F. Relationship between salt sensitivity of blood pressure and sympathetic nervous system activity: a short review of evidence. Clin Exp Hypertens 23: 25-33, 2001.
114. Sun JZ, Chen SH, Majid-Hasan E, Oparil S, and Chen YF. Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP. Am J Physiol Renal Physiol 282: F220-F227, 2002.
115. Sun XY, Feng QP, Gong QL, Edvinsson L, and Hedner T. Cardiovascular and renal effects of gamma-MSH in spontaneously hypertensive and normotensive Wistar Kyoto rats. Am J Physiol Regul Integr Comp Physiol 262: R77-R84, 1992.
116. Thiemermann C, Al-Damluji S, Hecker M, and Vane JR. FMRFamide and L-Arg-L-Phe increase blood pressure and heart rate in the anesthetized rat by central stimulation of the sympathetic nervous system. Biochem Biophys Res Commun 175: 318-324, 1991.
117. Tsigo C, Arai K, Hung W, and Chrousos GP. Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J Clin Invest 92: 2458-2461, 1993.
118. Vaisse C, Clement K, Durand E, Hercherg S, Guy-Grand B, and Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106: 253-262, 2000.
119. Valdemarsson S, Andersson D, Bengtsson A, Bogren M, Edvinsson L, and Ekman R. Gamma 2-MSH increases during graded exercise in healthy subjects: comparison with plasma catecholamines, neuropeptides, aldosterone and renin activity. Clin Physiol 10: 321-327, 1990.
120. 2-MSH). Naunyn Schmiedebergs Arch Pharmacol 355: 720-726, 1997.
121. Van Bergen P, Janssen PML, Hoogerhout P, De Wildt DJ, and Versteeg DHG. Cardiovascular effects of γ-MSH/ACTH-like peptides: structure-activity relationship. Eur J Pharmacol 294: 795-803, 1995.
122. 2-MSH and ACTH-(1-24). Br J Pharmacol 120: 1561-1567, 1997.
123. Van Bergen P, Van der Vaart JGM, Kasbergen CM, Versteeg DHG, and De Wildt DJ. Structure-activity analysis for the effects of γ-MSH/ACTH-like peptides on cerebral hemodynamics in rats. Eur J Pharmacol 318: 357-368, 1996.
124. Versteeg DHG, Van Bergen P, Adan RAH, and De Wildt DJ. Melanocortins and cardiovascular regulation. Eur J Pharmacol 360: 1-14, 1998.
125. Wardlaw SL. Obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 86: 1442-1446, 2001.
126. Weber A, Kapas S, Hinson J, Grant DB, Grossman A, and Clark AJL. Functional characterization of the cloned human ACTH receptor: impaired responsiveness of a mutant receptor in familial glucocorticoid deficiency. Biochem Biophys Res Commun 197: 172-178, 1993.
127. Westphal CH, Muller L, Zhou A, Zhu X, Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I, and Leder P. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 96: 689-700, 1999.
128. Wikberg JES, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, and Skottner A. New aspects on the melanocortins and their receptors. Pharmacol Res 42: 393-420, 2000.
129. Wilkes NM, Watkin S, Stewart RD, and Yen SSC. Localization and quantitation of β-endorphin in human brain and pituitary. Neuroendocrinology 30: 113-121, 1980.
130. Yaswen L, Diehl N, Brennan MB, and Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5: 1066-1070, 1999.
131. Yeo GSH, Farooqi IS, Challis BG, Jackson RS, and O'Rahilly S. The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. QJM 93: 7-14, 2000.
132. Ying WZ, Wiedemann E, and Humphreys MH. Captopril treatment restores the responsiveness of spontaneously hypertensive rats (SHR) to the natriuretic action of intrarenal γ-melanocyte stimulating hormone (γ-MSH) (Abstract). J Am Soc Nephrol 3: 529, 1992.
133. Zhou A, Bloomquist BT, and Mains RE. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 268: 1763-1769, 1993.
134. Zhou A, Webb G, Zhu X, and Steiner DF. Proteolytic processing in the secretory pathway. J Biol Chem 274: 20745-20748, 1999.